Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2005
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591124A1 Galenic preparation for anal administration in the treatment of haemorrhoids
11/02/2005EP1590449A2 Icos+ suppresser t cells
11/02/2005EP1590448A1 Method of preparing cell for transplantation
11/02/2005EP1590047A1 Composition comprising lactobacilli or bifidobacteria and use thereof
11/02/2005EP1589982A1 Packs on the base of chalk and paraffin
11/02/2005EP1589981A2 Interferon antagonists useful for the treatment of interferon related diseases
11/02/2005EP1589834A1 Enteral composition for the prevention and/or treatment of sepsis
11/02/2005EP1290145B1 Three-dimensional skin model
11/02/2005EP1067944B1 Combined preparation comprising monocyte derived cells and chemotherapy drugs for the treatment of neoplasic diseases or of infectious diseases
11/02/2005EP0974056B1 Prenatal diagnostic methods in vitro
11/02/2005EP0901521B1 Antigenic modulation of cells
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1691951A Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds
11/02/2005CN1691950A Method of treating biological tissue for transplantation by applying ultrahigh hydrostatic pressure
11/02/2005CN1689587A Method for processing nano ant powder
11/02/2005CN1689586A Application of nano propolis in resistance of influenza virus, respiratory syncytial virus and bird infected bronchitis virus
11/02/2005CN1225467C Diazocines compound and method for preparing it using slime bacteria fermentation and extraction method
11/01/2005US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960351 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/01/2005US6960342 Fungicides; controlling plant fungi
11/01/2005US6960341 Bifidobacteria and preparations containing them
10/2005
10/27/2005WO2005100563A1 Follistatin mutant polypeptide
10/27/2005WO2005100558A1 Cd40 ligand mutant and utilization of the same
10/27/2005WO2005100552A2 Cells exhibiting neuronal progenitor cell characteristics
10/27/2005WO2005100547A1 Dendritic cell obtained by antigen pulsing
10/27/2005WO2005100546A1 Reversibly immortalized mammalian liver cells and use thereof
10/27/2005WO2005100383A2 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection
10/27/2005WO2005099773A1 Use of erythropoietin for treatment of cancer
10/27/2005WO2005099758A2 Injectable bioartificial tissue matrix
10/27/2005WO2005099725A1 Preventive and/or remedy for inflammatory bowel diseases
10/27/2005WO2005049845A3 Oncolytic herpes simplex virus encoding a heterologous nitroreductase
10/27/2005WO2005040338A3 Constrained alkaloid immunogens and antibodies and uses thereof
10/27/2005WO2005037854A3 Immunogenic peptides
10/27/2005WO2004078917A3 Expansion of renewable stem cell populations using modulators of pi 3-kinase
10/27/2005WO2004068109A3 Autologous or homologous coagulant produced from anticoagulated whole blood
10/27/2005US20050239904 Polycosanols from Ericerus pela wax
10/27/2005US20050239897 Mesenchymal stem cells and uses therefor
10/27/2005US20050239686 Methods and compositions for optimization of oxygen transport by cell-free systems
10/27/2005US20050239202 Methods and compositions for inhibiting the function of polynucleotide sequences
10/27/2005US20050239201 Methods of inducing differentiation of stem cells into a specific cell lineage
10/27/2005US20050239069 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy
10/27/2005US20050239040 System for producing mammalian pre-embryo and stem cell having better quality; co-culturing of oocytes and spermatozoa in lowered oxygen tension
10/27/2005US20050238688 Method of preparing an immunologically inert graft material from body tissue and material made with the method
10/27/2005US20050238670 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections
10/27/2005US20050238666 Methods of enhancing stem cell engraftment
10/27/2005US20050238637 Vectors for molecule delivery to CD11b expressing cells
10/27/2005US20050238636 Food supplement formulation
10/27/2005US20050238631 Methods and compositions for preventing biofilm formation, reducing existing biofilms, and for reducing populations of bacteria
10/27/2005US20050238630 A Lactobacillus acidophilus strain in combination with a Propionibacterium freudenreichii strain, used to administer to ruminants to inhibit infrection by Escherichia coli, Escherichia coli O157: H7, Salmonella Spp., Salmonella typhimurium, Shigella Spp., and Staphylococcus aureus.
10/27/2005US20050238625 Muscle-derived cells (MDCs) for promoting and enhancing nerve repair and regeneration
10/27/2005US20050238623 Method for treating mammals with modified mammalian blood
10/27/2005US20050238622 Compositions and methods for treating cancer with an oncolytic viral agent
10/27/2005US20050238590 Incorporation of exogenous lactic bacteria into the oral microflora
10/27/2005DE202005010676U1 Gel, useful for the treatment of summer eczema, comprises onion bulbs, garlic cloves, sugar, water and starch
10/27/2005DE102004018347A1 Wundheilungsfördende Botenstoffmischung Wundheilungsfördende messenger mixture
10/27/2005CA2562885A1 Follistatin variant polypeptide
10/27/2005CA2562473A1 Preventive and/or therapeutic agent for inflammatory bowel diseases
10/27/2005CA2562198A1 Cells exhibiting neuronal progenitor cell characteristics
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589099A1 Immortalized natural killer cell line
10/26/2005EP1588718A1 Gene therapy of hepatocyte growth factor to enhance muscular and cutaneous flap survival
10/26/2005EP1588713A1 Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles
10/26/2005EP1588712A1 Modulators of regulatory proteins
10/26/2005EP1588711A1 Composition trapping radicals in organism
10/26/2005EP1587913A1 New strains of bifidobacterium having the ability to produce glutamine
10/26/2005EP1587545A2 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
10/26/2005EP1587520A1 Bacteriophage for the treatment of bacterial biofilms
10/26/2005EP1587515A1 Biologic skin repair and enhancement
10/26/2005EP1539972A4 Methods for inducing differentiation of embryonic stem cells and uses thereof
10/26/2005EP1443983B1 Nerve repair unit and method of producing it
10/26/2005EP1018884B1 METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS
10/26/2005EP0975226B1 Cell-coated supports
10/26/2005EP0973727B1 Activated iododerivatives for the treatment of cancer and aids
10/26/2005EP0951289B1 Use of mycobacterium vaccae for treating chronic fatigue syndrome
10/26/2005CN1688701A Mechanisms of myoblast transfer in treating heart failure
10/26/2005CN1688330A Method for cancer therapy using herbal extracts
10/26/2005CN1688326A 抗老化剂 Anti-aging agent
10/26/2005CN1688324A Defensins use as antiviral agents
10/26/2005CN1688323A Lentiviral vector-mediated gene transfer and uses thereof
10/26/2005CN1688196A Hematopoietic stem cells and methods of treatment neogenesis vascular ophthalmopathy
10/26/2005CN1687107A Method for separating purified immuno regulation active polypeptide from placenta of cattle
10/26/2005CN1686183A Toad cake freeze dried powder injection agent and its preparation method
10/26/2005CN1686182A Medicinal preparation for supplementing calcium, magnesium and vitamin D
10/26/2005CN1686181A High brightness pearl and its preparation method
10/26/2005CN1686180A Application of active biological product in preparing anti HIV medicine
10/26/2005CN1686179A Anterior pituitary adrenocortical extract nano-liposome composite medicine, its preparation method and use
10/26/2005CN1686178A Specific medicine capable of preventing and treating post wound, post operation, postpartum
10/26/2005CN1686177A Production method of zhutaisu (pig's born vegetarian)
10/26/2005CN1686176A Medicine for treating child hernia and its preparation method
10/26/2005CN1686175A Natural calculus bovis in vitro breeding method
10/26/2005CN1686174A Tumour inhibitor formula for preventing and treating malignant tumour
10/26/2005CN1686173A Active liver cytokine composition and its preparation method
10/26/2005CN1686172A Medicinal composition for treating and improving brain function, its preparation method and application
10/26/2005CN1686171A Muscle refining extract, its preparation method and application
10/26/2005CN1686170A Velvel deerhorn extract freeze dried powder injection agent and its preparation method
10/26/2005CN1686169A Velvet deerhorn drip pill and its preparation method
10/26/2005CN1686168A Anticoid factor activator compound injection agent capable of treating arthritis
10/26/2005CN1686167A Naobishu freeze dried powder injection agent and its preparation method
1 ... 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 ... 1259